Pharmafile Logo
Pharmafocus logo
Advanced Search
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

Appointment
640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016
Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …

News

Japan announces measure to crack down on drug pricing

December 20, 2016
Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo

Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …

News

J&J’s largest India site to finally operate by 2018

December 20, 2016
Manufacturing and Production India, Johnson & Johnson

Johnson & Johnson has reportedly announced that its manufacturing plant in Telangana, India, its largest site in the country, is …

News

AstraZeneca opens £120 million UK manufacturing facility

December 20, 2016
Manufacturing and Production AstraZeneca, Macclesfield

AstraZeneca has officially opened a new manufacturing facility for cancer medicines based in Macclesfield, UK. It becomes the second largest …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 19, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

News
ionis

Ionis achieves successful Phase 3 trial to treat rare diseases

December 19, 2016
Manufacturing and Production, Research and Development Akcea, Ionis, rare disease

Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …

News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016
Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …

News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …

Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016
Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …

News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016
Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

News
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016
Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …

News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016
Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …

News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …

Appointment
nurofen

Nurofen maker hit by $6m fine over “misleading conduct”

December 16, 2016
Sales and Marketing Nurofen, Reckitt Benckiser

After a case last year levied by the Australian Federal Court over “misleading conduct” concerning the marketing of its branded …

News
1511671_logo_1456919640

MSD-Gilead patent squabble ends in $2.54 billion verdict

December 16, 2016
Medical Communications

A patent lawsuit between Gilead Sciences and MSD, known as Merck in the US, has resulted in MSD being awarded …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 16, 2016
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …

News
dominos

Six generics companies hit by 20-state-strong lawsuit

December 16, 2016
Medical Communications Heritage, Mylan, Teva

Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …

News

Actavis UK overcharged NHS with 12,000% price hike, watchdog says

December 16, 2016
Medical Communications, Sales and Marketing Actavis, CMA, NHS

Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026